Replies to post #5553 on US Stem Cell Inc (USRM)

[Gaintrader]

Agreed, At the point when stem cell therapies become mainstream, the criteria determining who the leaders are will be;

1. safety
2. effectiveness
3. cost

First to market will not matter much if better and more cost effective therapies are proven later to be "best in breed".